查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1809812

GMP级细胞培养基市场（依产品类型、成分、形式、细胞类型和应用）－2025-2030年全球预测

GMP Grade Cell Culture Media Market by Product Type, Component, Form, Cell Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2024 年 GMP 级细胞培养基市场价值将达到 78.9 亿美元，2025 年将成长至 86.7 亿美元，复合年增长率为 10.05%，到 2030 年将达到 140.2 亿美元。

主要市场统计数据
基准年2024年 78.9亿美元
预计2025年 86.7亿美元
预测年份 2030 140.2亿美元
复合年增长率（%） 10.05%

利用高品质 GMP 级细胞培养基开拓生物加工的未来，加速治疗与研究创新

随着生物製药需求的不断增长，高纯度、符合法规要求的细胞培养基的角色变得前所未有的重要。随着生物製程日益复杂，上游製造的挑战促使人们不断追求能够实现稳定细胞生长、最佳产品产量以及与严格品质标准无缝整合的培养基配方。本介绍强调了GMP级细胞培养基的根本重要性，它推动了疫苗生产、单株抗体合成、基因治疗和前沿研究领域的突破。透过为哺乳动物和微生物系统提供稳定、可重复的环境，这些专用培养基既能促进现有製程的实施，又能促进新方法的开发。

新技术和永续性正在重新定义 GMP 级细胞培养基市场的标准和供应链

在过去十年中，在自动化、数位化和永续性概念的推动下，细胞培养基市场发生了翻天覆地的变化。人工智慧驱动的生物製程优化工具能够即时监控培养条件，减少人工劳动，并最大限度地降低批次间差异。同时，连续生产平台已成为传统批量生产流程的可行替代方案，减少了占地面积并提高了资源利用率。因此，培养基配方也在不断发展，以支持灌注和强化上游工程，同时又不影响产品品质。

评估2025年美国新关税政策对细胞培养基供应链、成本结构和策略采购的影响

2025年，美国将对关键原料和中间产品实施新关税，这将重塑整个细胞培养基产业的筹资策略和成本结构。迄今为止，供应商一直依赖全球製造商网路来采购胺基酸、微量元素和专用生长因子等成分。随着主要地区进口关税的提高，企业将需要重新评估其供应商关係，并考虑其他供应商地区，以在不影响品质或合规性的前提下保持成本竞争力。

发现推动产品类型、成分、形式、细胞类型和应用创新和需求的关键市场区隔模式

了解市场区隔对于识别有前景的领域并根据特定最终用户需求客製化产品至关重要。按产品类型检验市场发现，化学成分确定的培养基、常规培养基、无血清培养基、CHO 和 VERO 细胞培养基以及特种培养基，每个细分市场都需要独特的配方策略和品管，以支持多样化的生物製造工作流程。

检验美洲、欧洲、中东和非洲以及亚太地区细胞培养基领域的区域动态和驱动因素

由于研发重点、製造投资和法律规范的变化，区域市场动态持续演变。在美洲，强大的生物製药丛集正在催生对先进细胞培养基前所未有的需求。北美主要中心的特点是强大的产学合作和新治疗方法的加速应用，从而推动了对高性能培养基配方的旺盛需求。同时，随着本地製造能力的提升和区域供应链的成熟，拉丁美洲市场正经历温和成长。

在细胞培养基领域形成研发、製造卓越和伙伴关係的主要企业的策略和营运亮点

细胞培养基领域的主要企业正在采取多管齐下的策略来保持竞争优势并扩大市场份额。一些公司正在投资专有配方和製程改进技术，使其能够提供性能卓越的培养基，例如提高细胞活力并减少代谢物累积。其他公司则优先考虑在多个大洲扩建GMP认证的生产设施，以确保供应的连续性并符合当地的监管要求。

为相关人员提供战术性策略，以增强细胞培养基供应弹性、法规遵循和创新性

行业领导者可以透过多元化原材料来源和签订双源协议来巩固其市场地位，以减轻地缘政治变化和关税波动的影响。投资自动化和模组化生产线不仅可以加速规模化生产，还能提高批次一致性并减少劳力密集流程。同时，将永续性原则融入培养基配方和设施运作中，可以吸引具有环保意识的最终用户，并支持长期合规性。

了解我们严谨的研究框架，结合质性访谈、原始资料蒐集和量化分析，取得可靠的市场情报。

本书提出的见解建立在一个严谨的研究框架之上，融合了定性和定量方法。最初的案头研究包括对科学论文、专利申请、监管指南和企业资料的全面审查，以建立基本背景并识别关键的市场驱动因素。

洞察摘要和重点策略要点，助力不断发展的 GMP 级细胞培养基生态系统实现持续成长

随着GMP级细胞培养基市场的不断发展，技术创新、永续性要求和监管复杂性的整合将决定竞争格局。积极拥抱数位化工具、投资敏捷製造解决方案并建立弹性供应链的相关人员将开闢新的成长和差异化途径。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 增加对自动化培养基製备平台的投资，以提高 GMP 合规性和生产吞吐量
  • 品管系统的出现，优化了 GMP 培养基製造中的可追溯性和文件记录
  • 生物製药製造商与培养基供应商之间的策略伙伴关係关係加速了供应链的弹性
  • 过渡到无异源培养基符合安全和合规要求
  • 化学定义的 GMP 培养基配方的进步降低了治疗细胞生产的差异性
  • 个人化细胞治疗管道的成长推动客製化 GMP 级细胞培养基的发展
  • 一次性系统改变 GMP 培养基的生产和扩充性
  • 整合无动物成分的 GMP 配方，以满足培养基製造中的监管和永续性目标
  • 一次性生物反应器系统的引入正在推动对符合 GMP 标准的细胞培养基的需求
  • 加速无血清培养基的研究和开发，以提高可重复性和安全性

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. GMP级细胞培养基市场（依产品类型）

  • 化学成分确定的培养基
  • 古典媒体
  • 无血清培养基
    • CHO培养基
    • VERO细胞培养基
  • 专业媒体

9. GMP级细胞培养基市场（依成分）

  • 胺基酸
  • 生长因子
  • 荷尔蒙
  • 微量元素
  • 维他命

10. GMP级细胞培养基市场（依形式）

  • 液体培养基
  • 粉状培养基

第 11 章 GMP 级细胞培养基市场（依细胞类型）

  • 鸟细胞
  • 细菌细胞
  • 昆虫细胞
  • 哺乳动物细胞
  • 酵母菌细胞

第12章 GMP级细胞培养基市场（依应用）

  • 生物製药製造
    • 单株抗体（mAb）的生产
    • 重组蛋白生产
    • 疫苗生产
  • 细胞及基因治疗製造
    • 细胞疗法
    • 基因治疗
    • 再生医学
  • 研究与发展（R&D）
    • 基础细胞生物学研究
    • 药物研发
    • 体外建模
    • 製程开发与最佳化

13. 美国GMP级细胞培养基市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. EMEA GMP 级细胞培养基市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15. 亚太地区GMP级细胞培养基市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Avantor, Inc.
    • Bio-Techne Corporation
    • BioLife Solutions Inc.
    • Cook Group Incorporated
    • Corning Incorporated
    • FUJIFILM Holdings Corporation
    • Gemini BioProducts LLC
    • HiMedia Laboratories Pvt. Ltd
    • InVitria
    • Lonza Group Ltd.
    • Merck KGaA
    • Miltenyi Biotec BV & Co. KG
    • MP Biomedicals, LLC
    • PromoCell GmbH
    • Sartorius AG
    • STEMCELL Technologies Canada Inc.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc
    • Plant Cell Technology Inc
    • PAN-Biotech GmbH
    • ACROBIOSYSTEMS INC
    • Danaher Corporation
    • Capricorn Scientific GmbH
    • Elabscience Bionovation Inc.
    • Shanghai BioEngine Sci-Tech Co., Ltd.
    • Becton, Dickinson and Company

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-4F7A6D4FD889

The GMP Grade Cell Culture Media Market was valued at USD 7.89 billion in 2024 and is projected to grow to USD 8.67 billion in 2025, with a CAGR of 10.05%, reaching USD 14.02 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 7.89 billion
Estimated Year [2025] USD 8.67 billion
Forecast Year [2030] USD 14.02 billion
CAGR (%) 10.05%

Pioneering the Future of Bioprocessing with High-Quality GMP Grade Cell Culture Media to Accelerate Therapeutic and Research Innovations

In the face of mounting demands for biopharmaceutical products, the role of high-purity, regulatory-compliant cell culture media has grown more critical than ever before. As bioprocessing complexity increases, upstream manufacturing challenges drive relentless pursuit of media formulations that deliver consistent cell growth, optimal product yield, and seamless integration within stringent quality standards. This introduction underscores the fundamental importance of GMP grade cell culture media in enabling breakthroughs across vaccine production, monoclonal antibody synthesis, gene therapies, and cutting-edge research endeavors. By providing a stable and reproducible environment for mammalian and microbial systems, these specialized media facilitate both established processes and emergent modalities.

Transitioning from generic formulations to GMP compliant manufacturing practices demands robust supply chain management and rigorous in-process controls. Companies must navigate evolving global and regional regulations, while maintaining flexibility to accommodate novel process intensification strategies. Close collaboration between media suppliers, biomanufacturing facilities, and regulatory authorities has emerged as a cornerstone for mitigating risks and ensuring that quality attributes align with therapeutic end use.

In the sections that follow, this document will explore transformative technological shifts reshaping the sector, assess the forthcoming tariff landscape in key markets, highlight critical segmentation insights across multiple dimensions, and examine regional growth drivers. Further, strategic perspectives on leading industry players, actionable recommendations for supply resilience, and a comprehensive research methodology will provide a solid foundation for informed decision-making. Ultimately, this executive summary sets the stage for a deep dive into sustainable growth opportunities and best practices for navigating a complex and dynamic market environment.

How Emerging Technologies and Sustainability Imperatives Are Redefining Standards and Supply Chains in the GMP Grade Cell Culture Media Market

Over the past decade, the cell culture media landscape has witnessed transformative shifts driven by advancements in automation, digitalization, and sustainability imperatives. Artificial intelligence-enabled bioprocess optimization tools now allow real-time monitoring of culture conditions, thereby reducing manual interventions and minimizing batch-to-batch variability. At the same time, continuous manufacturing platforms are emerging as viable alternatives to traditional batch processes, offering reduced footprint and improved resource utilization. Consequently, media formulations are evolving to support perfusion and intensified upstream processes without compromising on quality attributes.

Parallel to technological innovations, environmental considerations have become integral to product development strategies. Suppliers are prioritizing the use of renewable raw materials, adopting closed-loop systems for water and energy recovery, and enhancing trace element sourcing to comply with increasingly stringent ecological guidelines. Such initiatives not only minimize carbon footprints but also appeal to stakeholders who emphasize corporate social responsibility alongside scientific excellence.

Moreover, the integration of modular facility designs has enabled faster scale-up and modular expansion, effectively reducing time to market for novel therapies. Coupled with strategic partnerships between media developers, equipment manufacturers, and contract development and manufacturing organizations, these shifts signal a new era wherein agility and sustainability are at the forefront. As a result, companies that embrace these transformative trends will be best positioned to drive next-generation bioprocessing innovations and deliver high-value therapeutics with greater efficiency and reduced environmental impact.

Assessing the Repercussions of New US Tariff Policies in 2025 on Supply Chains, Cost Structures, and Strategic Sourcing in Cell Culture Media

In 2025, the introduction of revised United States tariffs on critical raw materials and intermediary products is poised to reshape sourcing strategies and cost structures across the cell culture media industry. Historically, suppliers have relied on a global network of manufacturers for components such as amino acids, trace elements, and specialized growth factors. With increased duties on imports from key regions, organizations must reassess vendor relationships and consider alternative supplier geographies to maintain cost competitiveness without compromising on quality or regulatory compliance.

This impending tariff regime will have a ripple effect on inventory planning, as companies reevaluate safety stock levels to buffer against potential supply chain disruptions. Advanced procurement teams are already collaborating with logistics partners to explore nearshoring opportunities and diversify freight lanes, thereby mitigating the risk of port congestion and escalating freight costs. In parallel, cost engineers are examining opportunities to streamline media formulations, reducing reliance on high-cost inputs where feasible while preserving critical performance characteristics.

Furthermore, regulatory affairs teams must monitor evolving trade regulations, harmonizing import documentation and certification processes to avoid clearance delays. Strategic alliances with domestic contract manufacturers can also serve as a hedge against tariff-induced cost pressures, enabling organizations to leverage localized production capabilities. Ultimately, the cumulative impact of the 2025 tariff adjustments will reward those who adopt agile sourcing strategies, harness data-driven demand forecasting, and implement robust risk management frameworks that safeguard both supply continuity and profitability.

Unveiling Critical Market Segmentation Patterns That Drive Innovation and Demand Across Product Type, Component, Form, Cell Type, and Application

Understanding market segmentation is essential for identifying areas of high potential and tailoring product offerings to specific end-user needs. When examining the market by product type, which includes chemically defined media alongside classical media, serum-free media further split into CHO media and VERO cell media, and specialty media, it becomes evident that each niche demands distinct formulation strategies and quality controls to support diverse biomanufacturing workflows.

Considering media composition provides further clarity: formulations rely heavily on precise concentrations of amino acids and vitamins that drive cell proliferation, while growth factors and hormones fine-tune metabolic activity. Trace elements serve as indispensable co-factors in enzymatic pathways, and variations in their sourcing can significantly influence performance. This component-based perspective reveals opportunities for innovation in raw material purity and supply chain traceability.

The choice between liquid and powder media offers flexibility to manufacturers balancing ease of use with storage and logistical considerations. Liquid media deliver immediate availability but often require larger cold storage capacities, whereas powder forms offer extended shelf life and simplified transport logistics, enabling rapid preparation on demand.

Cell type segmentation highlights distinct requirements for Avian, Bacterial, Insect, Mammalian, and Yeast systems, each of which may necessitate tailored nutrient profiles and sterility standards. Finally, application-driven divides-ranging from biopharmaceutical manufacturing of monoclonal antibodies, recombinant proteins, and vaccines, to cell and gene therapy manufacturing such as cell therapy, gene therapy, and regenerative medicine, as well as basic cell biology research, drug discovery and development, in vitro modeling, and process development and optimization-underscore the need for specialized media solutions that align with specific process parameters and regulatory benchmarks.

Examining Regional Dynamics and Growth Drivers Across the Americas, Europe/Middle East & Africa, and Asia-Pacific in the Cell Culture Media Sector

Regional market dynamics continue to evolve, driven by shifting R&D priorities, manufacturing investments, and regulatory frameworks. In the Americas, strong biopharmaceutical clusters have fostered unparalleled demand for advanced cell culture media. Major hubs in North America are characterized by robust academic-industry collaborations and accelerated adoption of novel therapies, bolstering volume requirements for high-performance media formulations. Latin American markets, by contrast, are witnessing gradual growth as local manufacturing capabilities expand and regional supply chains mature.

Across Europe, the Middle East and Africa, the landscape is marked by diverse regulatory environments and varying levels of infrastructure maturity. Western Europe benefits from established biotech ecosystems and harmonized regulations, supporting broad deployment of continuous manufacturing platforms. Emerging markets in Eastern Europe and the Middle East are investing in capacity building to reduce dependency on imports, while African initiatives are gradually laying the foundations for sustainable vaccine production, driving incremental media consumption.

The Asia-Pacific region is experiencing explosive growth driven by significant government incentives for biopharmaceutical localization, burgeoning contract manufacturing capacity, and a rapidly expanding research community. Countries across East Asia have emerged as critical suppliers of raw materials, while South and Southeast Asian markets are scaling up CMO services and academic research, intensifying demand for both standard and specialty media solutions. Taken together, these regional trends reveal a complex tapestry of opportunities, with each geography presenting unique drivers for strategic investment and partnerships.

Strategic and Operational Highlights of Leading Players Shaping R&D, Manufacturing Excellence, and Partnerships in the Cell Culture Media Arena

Leading companies in the cell culture media domain have adopted multifaceted approaches to maintain competitive advantage and drive market share. Investment in proprietary formulation technologies and process intensification techniques has enabled some players to deliver media with superior performance attributes, such as enhanced cell viability and reduced metabolite accumulation. Others have prioritized the expansion of GMP-certified production facilities across multiple continents, thereby guaranteeing supply continuity and catering to local regulatory requirements.

Strategic collaborations with suppliers of raw materials and single-use technologies have further strengthened value propositions, allowing comprehensive end-to-end solutions for contract manufacturing and research organizations. Partnerships targeting co-development of novel feed supplements and real-time analytical tools are also fueling innovation in upstream process monitoring and control.

Beyond R&D and manufacturing capabilities, quality assurance remains a differentiator. Companies that secure international accreditations and implement advanced quality management systems instill greater confidence in end users, particularly within highly regulated therapeutic manufacturing segments. Meanwhile, targeted acquisitions of niche specialty media providers have expanded product portfolios, enabling rapid entry into emerging application areas such as gene therapy and personalized medicine.

Collectively, these strategic and operational highlights reflect a dynamic competitive environment where continuous innovation, geographic footprint expansion, and collaborative ecosystems are paramount to achieving long-term success in the cell culture media arena.

Empowering Industry Stakeholders with Tactical Strategies to Enhance Supply Resilience, Regulatory Compliance, and Innovation in Cell Culture Media

Industry leaders can strengthen their market positions by diversifying raw material sources and establishing dual sourcing agreements to mitigate the impact of geopolitical shifts and tariff fluctuations. Investing in automation and modular production lines not only accelerates scale-up but also enhances batch consistency and reduces labor-intensive processes. In parallel, integrating sustainability principles into media formulation and facility operations will appeal to environmentally conscious end users and support long-term regulatory compliance.

Collaboration with academic institutions, technology providers, and contract developers can expedite innovation cycles and unlock new applications. Joint development programs focused on perfusion media or serum-free alternatives will accelerate the adoption of high-value therapies. At the same time, deploying advanced analytics and machine learning models for demand forecasting and process optimization will improve decision-making and resource allocation.

Additionally, engaging early with regulatory authorities to align on emerging quality requirements can preempt compliance challenges. Building transparent traceability frameworks for critical components, including growth factors and trace elements, will further reinforce customer trust and facilitate approvals. Finally, prioritizing customer education through workshops and technical support services will catalyze deeper partnerships, positioning suppliers as indispensable stakeholders in clients' success stories.

Detailing Our Rigorous Research Framework Combining Qualitative Interviews, Primary Data Collection, and Quantitative Analysis for Credible Market Intelligence

The insights presented in this document are built upon a rigorous research framework that integrates qualitative and quantitative methodologies. Initial desk research encompassed an exhaustive review of scientific publications, patent filings, regulatory guidelines, and corporate disclosures to establish the foundational context and identify key market drivers.

Primary research involved in-depth interviews with senior executives, process engineers, and quality assurance specialists from leading media suppliers, contract manufacturing organizations, and end users. These conversations provided firsthand perspectives on operational challenges, formulation innovations, and supply chain dynamics. Data was then triangulated with secondary sources to validate assumptions and ensure accuracy.

Quantitative analysis applied advanced statistical techniques to historical consumption patterns and production capacities, enabling identification of growth pockets and competitive intensity. Throughout the process, stringent data quality checks and cross-referencing protocols were employed to guarantee methodological integrity and repeatability. The resulting framework offers a transparent and replicable approach to market intelligence, supporting confident decision-making underpinned by robust evidence.

Summarizing Insights and Highlighting Strategic Imperatives for Sustainable Growth in the Evolving GMP Grade Cell Culture Media Ecosystem

As the GMP grade cell culture media market continues to evolve, the convergence of technological innovation, sustainability imperatives, and regulatory complexity will define the competitive landscape. Stakeholders who proactively embrace digital tools, invest in agile manufacturing solutions, and cultivate resilient supply chains will unlock new avenues for growth and differentiation.

Segment-specific strategies, whether optimizing chemically defined media for high-density cultivation or tailoring specialty formulations for emerging cell therapies, will be critical for capturing value in niche applications. Meanwhile, regional nuances-from the mature markets of North America and Western Europe to the rapidly expanding bioprocessing hubs in the Asia-Pacific-demand customized approaches that align with local infrastructure and regulatory environments.

Ultimately, leveraging comprehensive market insights, fostering cross-industry collaborations, and maintaining a forward-looking perspective on policy changes will empower organizations to thrive in this dynamic ecosystem. By adhering to these strategic imperatives, companies can pave the way for sustainable innovation, operational excellence, and long-term success in the cell culture media sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rising investment in automated media preparation platforms enhancing GMP compliance and production throughput
  • 5.2. Emergence of digital quality management systems optimizing traceability and documentation in GMP media production
  • 5.3. Strategic partnerships between biopharma manufacturers and media suppliers accelerating supply chain resilience
  • 5.4. Shift toward xeno-free media aligns with safety and compliance demands
  • 5.5. Advances in chemically defined GMP media formulations reducing variability in therapeutic cell production
  • 5.6. Growth in personalized cell therapy pipelines fueling custom GMP grade cell culture media development
  • 5.7. Single-use systems transform GMP media manufacturing and scalability
  • 5.8. Integration of animal component-free GMP formulations to meet regulatory and sustainability goals in media manufacturing
  • 5.9. Adoption of single-use bioreactor systems driving demand for prequalified GMP cell culture media
  • 5.10. R&D in serum-free media accelerates for enhanced reproducibility and safety

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. GMP Grade Cell Culture Media Market, by Product Type

  • 8.1. Introduction
  • 8.2. Chemically Defined Media
  • 8.3. Classical Media
  • 8.4. Serum-Free Media
    • 8.4.1. CHO Media
    • 8.4.2. VERO Cell Media
  • 8.5. Specialty Media

9. GMP Grade Cell Culture Media Market, by Component

  • 9.1. Introduction
  • 9.2. Amino Acids
  • 9.3. Growth Factors
  • 9.4. Hormones
  • 9.5. Trace Elements
  • 9.6. Vitamins

10. GMP Grade Cell Culture Media Market, by Form

  • 10.1. Introduction
  • 10.2. Liquid Media
  • 10.3. Powder Media

11. GMP Grade Cell Culture Media Market, by Cell Type

  • 11.1. Introduction
  • 11.2. Avian Cells
  • 11.3. Bacterial Cells
  • 11.4. Insect Cells
  • 11.5. Mammalian Cells
  • 11.6. Yeast Cells

12. GMP Grade Cell Culture Media Market, by Application

  • 12.1. Introduction
  • 12.2. Biopharmaceutical Manufacturing
    • 12.2.1. Monoclonal Antibodies (mAbs) Production
    • 12.2.2. Recombinant Proteins Production
    • 12.2.3. Vaccine Production
  • 12.3. Cell & Gene Therapy Manufacturing
    • 12.3.1. Cell Therapy
    • 12.3.2. Gene Therapy
    • 12.3.3. Regenerative Medicine
  • 12.4. Research & Development (R&D)
    • 12.4.1. Basic Cell Biology Research
    • 12.4.2. Drug Discovery & Development
    • 12.4.3. In Vitro Modeling
    • 12.4.4. Process Development & Optimization

13. Americas GMP Grade Cell Culture Media Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa GMP Grade Cell Culture Media Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific GMP Grade Cell Culture Media Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Avantor, Inc.
    • 16.3.2. Bio-Techne Corporation
    • 16.3.3. BioLife Solutions Inc.
    • 16.3.4. Cook Group Incorporated
    • 16.3.5. Corning Incorporated
    • 16.3.6. FUJIFILM Holdings Corporation
    • 16.3.7. Gemini BioProducts LLC
    • 16.3.8. HiMedia Laboratories Pvt. Ltd
    • 16.3.9. InVitria
    • 16.3.10. Lonza Group Ltd.
    • 16.3.11. Merck KGaA
    • 16.3.12. Miltenyi Biotec B.V. & Co. KG
    • 16.3.13. MP Biomedicals, LLC
    • 16.3.14. PromoCell GmbH
    • 16.3.15. Sartorius AG
    • 16.3.16. STEMCELL Technologies Canada Inc.
    • 16.3.17. Takara Bio Inc.
    • 16.3.18. Thermo Fisher Scientific Inc
    • 16.3.19. Plant Cell Technology Inc
    • 16.3.20. PAN-Biotech GmbH
    • 16.3.21. ACROBIOSYSTEMS INC
    • 16.3.22. Danaher Corporation
    • 16.3.23. Capricorn Scientific GmbH
    • 16.3.24. Elabscience Bionovation Inc.
    • 16.3.25. Shanghai BioEngine Sci-Tech Co., Ltd.
    • 16.3.26. Becton, Dickinson and Company

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. GMP GRADE CELL CULTURE MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. GMP GRADE CELL CULTURE MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. GMP GRADE CELL CULTURE MEDIA MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. GMP GRADE CELL CULTURE MEDIA MARKET: RESEARCHAI
  • FIGURE 26. GMP GRADE CELL CULTURE MEDIA MARKET: RESEARCHSTATISTICS
  • FIGURE 27. GMP GRADE CELL CULTURE MEDIA MARKET: RESEARCHCONTACTS
  • FIGURE 28. GMP GRADE CELL CULTURE MEDIA MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. GMP GRADE CELL CULTURE MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CHEMICALLY DEFINED MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CHEMICALLY DEFINED MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CLASSICAL MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CLASSICAL MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CHO MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CHO MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VERO CELL MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VERO CELL MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AMINO ACIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY HORMONES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TRACE ELEMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TRACE ELEMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VITAMINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VITAMINS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY POWDER MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY POWDER MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AVIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AVIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES (MABS) PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES (MABS) PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BASIC CELL BIOLOGY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BASIC CELL BIOLOGY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY IN VITRO MODELING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY IN VITRO MODELING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PROCESS DEVELOPMENT & OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PROCESS DEVELOPMENT & OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 146. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 265. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 271. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 272. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 273. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 283. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 289. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL & GENE THERAPY MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 291. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH & DEVELOPMENT (R&D), 2025-2030 (USD MILLION)
  • TABLE 293. ITALY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY GMP GRADE CELL CULTURE MEDIA MARK